List of Excipients in API TOBRAMYCIN SULFATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing TOBRAMYCIN SULFATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Fresenius Kabi USA LLC | TOBRAMYCIN | tobramycin sulfate | 63323-303 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing TOBRAMYCIN SULFATE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Akorn | tobramycin sulfate | 17478-114 | EDETATE DISODIUM |
| Akorn | tobramycin sulfate | 17478-114 | PHENOL |
| Akorn | tobramycin sulfate | 17478-114 | SODIUM DITHIONATE |
| Akorn | tobramycin sulfate | 17478-114 | SODIUM HYDROXIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for TOBRAMYCIN SULFATE
Excipient focus: EDETATE DISODIUM
TOBRAMYCIN SULFATE drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | tobramycin sulfate | 17478-114 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-306 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-307 |
| >Company | >Ingredient | >NDC |
TOBRAMYCIN SULFATE drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-303 |
| >Company | >Ingredient | >NDC |
Excipient focus: PHENOL
TOBRAMYCIN SULFATE drug variants containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | tobramycin sulfate | 17478-114 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-306 |
| >Company | >Ingredient | >NDC |
TOBRAMYCIN SULFATE drug variants not containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-303 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-307 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM DITHIONATE
TOBRAMYCIN SULFATE drug variants containing SODIUM DITHIONATE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | tobramycin sulfate | 17478-114 |
| >Company | >Ingredient | >NDC |
TOBRAMYCIN SULFATE drug variants not containing SODIUM DITHIONATE
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-303 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-306 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-307 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
TOBRAMYCIN SULFATE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | tobramycin sulfate | 17478-114 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-306 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-307 |
| >Company | >Ingredient | >NDC |
TOBRAMYCIN SULFATE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-303 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
TOBRAMYCIN SULFATE drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-306 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-307 |
| >Company | >Ingredient | >NDC |
TOBRAMYCIN SULFATE drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | tobramycin sulfate | 17478-114 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-303 |
| >Company | >Ingredient | >NDC |
Excipient focus: SULFURIC ACID
TOBRAMYCIN SULFATE drug variants containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | tobramycin sulfate | 17478-114 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-306 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-307 |
| >Company | >Ingredient | >NDC |
TOBRAMYCIN SULFATE drug variants not containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-303 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
TOBRAMYCIN SULFATE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | tobramycin sulfate | 17478-114 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-303 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-306 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-307 |
| >Company | >Ingredient | >NDC |
TOBRAMYCIN SULFATE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
